Moods

DIMENSION NODE (MAXEL, DIMENSION CORD (MAXNP, DIMENSION MOOD (MAXDF DIMENSION IBC (MAXBC DIMENSION VEL (MAXDF DIMENSION CLUMP (MAXNP DIMENSION. /ET (MAXDF DIMENSION SIW (MAXEL,... 

The molten carbonate fuel ceU uses eutectic blends of Hthium and potassium carbonates as the electrolyte. A special grade of Hthium carbonate is used in treatment of affective mental (mood) disorders, including clinical depression and bipolar disorders. Lithium has also been evaluated in treatment of schizophrenia, schizoaffective disorders, alcoholism, and periodic aggressive behavior (56). 

Enkephalins and Endorphins. Morphine (142), an alkaloid found in opium, was first isolated in the early nineteenth century and widely used in patent medicines of that eta. It is pharmacologically potent and includes analgesic and mood altering effects. Endogenous opiates, the enkephalins, endorphins, and dynotphins were identified in the mid-1970s (3,51) (see Opioids, endogenous). Enkephalins and endorphins ate Hsted in Table 9. 

Opiates are useful analgesics because they reduce pain sensation without blocking feeling or other sensations. However, they also affect mood, iaduce euphoria, reduce mental acuity, and iaduce physical dependence. They can be immunosuppressive and dismpt other homeostatic processes through... 

Although odorous materials no doubt impact each other, much discussion centers around the abiUty of odorous materials to influence human behavior. In articles ranging from scientific journals to trade maga2ines, there is discussion on the potential of fragrances, ie, essential oils, to affect people s moods, their abiUty to focus and maintain attention, to relax and sleep, and even their sexual capabiUty. 

Consider these findings from studies that assess whether fragrance is a powerful mood-altering substance (9) ... 

Further to this, it should be possible to better understand how odors affect human moods and performance. Studies involving autistic cluldten, severely mentally handicapped persons, and traumatic and stress-related situations where odors are being used to affect behavior may open many more doors to the understanding (4). 

Treatment of Manic—Depressive Illness. Siace the 1960s, lithium carbonate [10377-37-4] and other lithium salts have represented the standard treatment of mild-to-moderate manic-depressive disorders (175). It is effective ia about 60—80% of all acute manic episodes within one to three weeks of adrninistration. Lithium ions can reduce the frequency of manic or depressive episodes ia bipolar patients providing a mood-stabilising effect. Patients ate maintained on low, stabilising doses of lithium salts indefinitely as a prophylaxis. However, the therapeutic iadex is low, thus requiring monitoring of semm concentration. Adverse effects iaclude tremor, diarrhea, problems with eyes (adaptation to darkness), hypothyroidism, and cardiac problems (bradycardia—tachycardia syndrome). 

Other agents are also used for the treatment of manic-depressive disorders based on preliminary clinical results (177). The antiepileptic carbamazepine [298-46-4] has been reported in some clinical studies to be therapeutically beneficial in mild-to-moderate manic depression. Carbamazepine treatment is used especially in bipolar patients intolerant to lithium or nonresponders. A majority of Hthium-resistant, rapidly cycling manic-depressive patients were reported in one study to improve on carbamazepine (178). Carbamazepine blocks noradrenaline reuptake and inhibits noradrenaline exocytosis. The main adverse events are those found commonly with antiepileptics, ie, vigilance problems, nystagmus, ataxia, and anemia, in addition to nausea, diarrhea, or constipation. Carbamazepine can be used in combination with lithium. Several clinical studies report that the calcium channel blocker verapamil [52-53-9] registered for angina pectoris and supraventricular arrhythmias, may also be effective in the treatment of acute mania. Its use as a mood stabilizer may be unrelated to its calcium-blocking properties. Verapamil also decreases the activity of several neurotransmitters. Severe manic depression is often treated with antipsychotics or benzodiazepine anxiolytics. 

Glassification of Substance-Related Disorders. The DSM-IV classification system (1) divides substance-related disorders into two categories (/) substance use disorders, ie, abuse and dependence and (2) substance-induced disorders, intoxication, withdrawal, delirium, persisting dementia, persisting amnestic disorder, psychotic disorder, mood disorder, anxiety disorder, sexual dysfunction, and sleep disorder. The different classes of substances addressed herein are alcohol, amphetamines, caffeine, caimabis, cocaine, hallucinogens, inhalants, nicotine, opioids, phencyclidine, sedatives, hypnotics or anxiolytics, polysubstance, and others. On the basis of their significant socioeconomic impact, alcohol, nicotine, cocaine, and opioids have been selected for discussion herein. 

However, clinical results with compounds enhancing cholinergic function have not been overly convincing (272). In the case of tacriae, however, the beneficial therapeutic iadex was sufficient to justify regulatory approval ia several countries. Psychostimulants such as pemoline, amphetamine, procaine, and methylphenidate have failed to show cognitive enhancing effects ia patients with dementia, except possibly as iadirect consequences of mood elevation. 

Monoamine Oxidase Inhibitors. MAOIs inactivate the enzyme MAO, which is responsible for the oxidative deamination of a variety of endogenous and exogenous substances. Among the endogenous substances are the neurotransmitters, norepinephrine, dopamine, and serotonin. The prototype MAOI is iproniazid [54-92-2] (25), originally tested as an antitubercular dmg and a close chemical relative of the effective antitubercular, isoniazid [54-85-3] (26). Tubercular patients exhibited mood elevation, although no reHef of their tuberculosis, following chronic administration of iproniazid. In... 

Mood, A. M. 1950 Introduction to the Theory of Statistics. NY McGraw-Hill. 

Monoamine oxidase (MAO) inactivates serotonergic and catecholaimnergic neurotransmitters MAO (A and B) inhibitors exhibit mood elevatmg properties 5-Fluoro-Ot-methyltryptamine 19) is an important MAO A-seleUive inhibitor In the treatment of certam depressive illnesses, 4-fluorotranylcypromine (20b) is 10 tunes more potent than the parent tranylcypromme (TCP, 20a) The enhanced m vivo activity may be due to increased lipophihcity at20b and/or to blockade of metabohc para hydroxylation [52]... 

Antidepressant. A drug that elevates the mood of individuals suffering from pathologic sadness. 

Modus, m. mode (of verba) mood, mdgen, v.i. be able, may like, choose. mSgl., abhrev. of moglich. 

Mut, m. courage, spirit humor, mood anger. Muter, m. claimant, petitioner, applicaut. mutig, a. spirited, courageous, mut-massen, v.i. guess, suppose, conjecture. 

Stimmung,/. tuning, tune, key, pitch mood morale. 

Weise,/. manner, custom, way Gram.) mood melody. — m. sage, philosopher. 

Arterial blood contains about 0.25 mg of oxygen per milliliter. What is the pressure exerted by the oxygen in one liter of arterial Mood at normal body temperature of 37°C ... 

And frankly, that s not a bad thing if that s what you ve come out for. Sex is a shot, like gin or vodka, and drinks have a blush-less and bold history of mood-producing—good and bad. You knock it back and you take your chances. 

The reality—Sake Sunrise, and the menu s other mood drinks, is a New Age wine cooler, a spa cocktail. But it s good, and it grows on you. You can feel it segue from weird liquor to nice, new taste like a smooth D.J. working two LPs. 

Affective (mood) disorders are characterized by changes in mood. The most common manifestation is depression, arranging from mild to severe forms. Psychotic depression is accompanied by hallucinations and illusions. Mania is less common than depression. In bipolar affective disorder, depression alternates with mania. 

---